ロード中...
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
We developed a test to predict which patients will achieve pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and which will have residual disease (RD). Gene expression data from pretreatment biopsies of patients with all breast cancer subtypes were combined into a 519-patient co...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795899/ https://ncbi.nlm.nih.gov/pubmed/31619719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-51335-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|